Prevalence Of Constipation In Patients With Advanced Kidney Disease by Lee, Anna et al.
University of Wollongong 
Research Online 
Faculty of Science, Medicine and Health - 
Papers: part A Faculty of Science, Medicine and Health 
2016 
Prevalence Of Constipation In Patients With Advanced Kidney Disease 
Anna Lee 
Illawarra Shoalhaven Local Health District 
Kelly Lambert 
University of Wollongong, klambert@uow.edu.au 
Pauline Byrne 
Illawarra Shoalhaven Local Health District, pb868@uow.edu.au 
Maureen A. Lonergan 
Illawarra Shoalhaven Local Health District, maureenl@uow.edu.au 
Follow this and additional works at: https://ro.uow.edu.au/smhpapers 
 Part of the Medicine and Health Sciences Commons, and the Social and Behavioral Sciences 
Commons 
Recommended Citation 
Lee, Anna; Lambert, Kelly; Byrne, Pauline; and Lonergan, Maureen A., "Prevalence Of Constipation In 
Patients With Advanced Kidney Disease" (2016). Faculty of Science, Medicine and Health - Papers: part A. 
5485. 
https://ro.uow.edu.au/smhpapers/5485 
Research Online is the open access institutional repository for the University of Wollongong. For further information 
contact the UOW Library: research-pubs@uow.edu.au 
Prevalence Of Constipation In Patients With Advanced Kidney Disease 
Abstract 
Background: For people on peritoneal dialysis (PD), constipation is associated with technique failure. For 
those on haemodialysis (HD), constipation has been associated with a reduction in quality of life. 
Objectives: The objectives of this study were to (i) determine the prevalence of functional constipation; (ii) 
compare patient perception of constipation with Rome III criteria for functional constipation; (iii) describe 
the prevalence of constipation and stool form using Bristol Stool Form Scale (BSFS); (iv) determine 
differences in bowel habit and stool form between those on dialysis compared to pre-dialysis; and (v) 
determine the diagnostic accuracy of self-perception and the Rome III criteria against the BSFS. A cross-
sectional group of pre-dialysis (eGFR < 15 ml/min) and dialysis patients were recruited. A total of 148 
patients participated (98 HD, 21 PD and 21 pre-dialysis). Participants: Completed a questionnaire 
consisting of self-perception of the presence of constipation, simplified questions from the Rome III 
criteria for functional constipation, scored their stool form using the BSFS and reported laxative use. 
Results: The prevalence of constipation using the Rome III criteria was 12.3%; patient perception 46.3% 
and 25.7% using the BSFS. Prevalence differed according to the tool used. Conclusion: No single method 
alone is sufficient for accurately determining if a patient is constipated. Relying on patients' self-
perception may be unreliable. Ideally patient assessment of constipation should incorporate both the 
Rome III criteria and BSFS in a method such as the one designed as a result of this research. Further 
research is needed to assess its usability and practicality in clinical practice. 
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Constipation is a common medical condition associated with increased healthcare costs and 
impaired quality of life. There are numerous factors that contribute to constipation such as 
low fibre diet and low fluid intake, poor or low levels of mobility, lack of exercise, anxiety, 
depression, chronic medical conditions such as diabetes, medications such as opioids and 
increasing age. (Huether, 2006; Digestive Health Foundation, 2007; Johanson & Kralstein, 
2007; JBI 2008; Selby & Corte,2010; Lee, 2011 Markland & Burgio,2013).  
For people with Chronic Kidney Disease (CKD) constipation can be problematic especially for 
those on dialysis. In this patient group, constipation is compounded by diet and fluid 
restrictions, physical inactivity and medications such as phosphate binders and resins which 
all add to the problem (Adams, 1982; Chambers, 1983; Stone, 1977; Yasuda et al, 1995; 
Hung et al, 2007, JBI 2015).  
For people on peritoneal dialysis (PD), constipation is associated with technique failure either 
due to peritoneal catheter migration, malfunction or peritonitis (Gokal et al, 1998, Li et al, 
2010,Sutton et al 2014). In people on haemodialysis (HD) constipation has been associated 
with a reduction in quality of life and as a contributing factor to malnutrition (Hung et al 2007; 
Nakabayashi et al 2011).  People on HD have a higher prevalence of and more severe 
constipation compared to those on PD (Zhang et al 2013; Dong et al 2014).The reasons for 
this remain unexplored. It may be possible that because constipation does not directly 
interfere with the HD procedure, it may be poorly reported.  
The reliance on self reporting is difficult when diagnosing constipation, as people’s perception 
may not accurately indicate the actual problem (Lee, 2011). This is a major negative aspect 
of research as people’s perception of constipation or altered bowel function is not clearly 
defined nor are assessment tools consistently utilised. In some studies the use of 
assessment tools have found that the rate of constipation is considerably higher when based 
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on self reported definitions probably due to personal perception rather than the actual 
problem (Lee, 2011) 
 
The Bristol Stool Form Scale (BSFS) and the Rome criteria are two validated methods that 
can be used to assess constipation. The BSFS describes stool form using seven (7) 
categories, with images as well as written descriptions (Lewis & Heaton 1997.)The Rome 
criteria (Garrigues et al., 2004; Pappas et al., 2008; Rome Foundation, 2010; Selby & Corte, 
2010) are used to diagnose constipation and other bowel disorders. Constipation must 
include at least 2 of the following criteria, less than 3 defecations per week, straining during 
defecation, hard or lumpy stools, sensation of incomplete evacuation, manual manoeuvre to 
facilitate defecation or sensation of anal blockage during defecation. It can therefore be used 
as a clinical tool to define and identify functional and / or chronic constipation. The version 
used in this study is the Rome III.  There are many causes of constipation but for the purpose 
of this study only functional constipation was assessed; that is constipation that has no 
underlying disease (Pare & Fedorak 2014)  
Utilising a group of patients with CKD, the objectives of this study were to 
1. determine the prevalence of functional constipation (as per Rome III criteria) 
2.  compare patient perception of constipation with Rome III criteria for functional 
constipation 
3. describe the prevalence of constipation and stool form using BSFS 
4. determine if there are differences in bowel habit and stool form between those on dialysis 
compared to pre dialysis 





Methods   
A cross sectional group of pre dialysis (eGFR < 15 ml/min) and dialysis patients were 
recruited from a large regional health service. Exclusion criteria included those patients under 
the care of a nephrologist with an eGFR ≤15 mLs/min and opting for conservative 
management; those undertaking dialysis for less than three months; kidney transplant 
recipients; patients with a colostomy or ileostomy and those with inadequate English 
language skills to complete a written questionnaire.  
 
Potential participants were approached and verbally informed of the project by either the 
principle investigator or a co investigator at a time of attending the renal service either for 
haemodialysis or a medical/nursing clinical appointment. A participant information sheet was 
provided and potential participants were encouraged to read the information and discuss the 
project with family or a carer. Participants were not required to attend outside their normal 
dialysis hours or follow up visit appointment minimising any inconvenience to them. Written 
consent was obtained from each participant. 
 
Participants were asked to complete a questionnaire about their bowel habits. This consisted 
of a simple version of the questions contained in the Rome III criteria for diagnosis of 
functional constipation questions relating to self perception of the presence of constipation 
(Appendix 1) and scoring of their stool using the BSFS 
(http://upload.wikimedia.org/wikipedia/commons/b/b4/Bristol_Stool_Chart.p) 
Participants were also asked to document any laxatives or aperient used. Basic demographic 
data regarding age, duration of renal replacement therapy was recorded. Research Ethics 




Statistical analysis was performed using SPSS Statistics for Windows version 21(SPSS, 
Chicago, IL, USA). Normality was assessed using the Shapiro Wilk test. Differences between 
groups or in the proportions between groups were evaluated using either the ANOVA or Chi 
Square tests. Pearson’s correlation was used to investigate the relationship between relevant 
variables and the presence of constipation. Sensitivity and specificity values were calculated 
to determine agreement between the presence of constipation (evaluated using the BSFS as 
the gold standard) and relavant variables.  The kappa coeffient and receive operator 
characteristic curves were calculated to determine the agreement and diagnostic accuracy of 
relevant variables compared to the BSFS. AUC values of <0.7 (poor test); 0.7-09 (fair to good 
test) and >0.9 (Excellent test) were used.  A p value of <0.05 was considered significant for 
all analyses. Results were also interpreted for clinical importance, that is, were the results 
meaningful and of practical importance to clinicians.  
 
RESULTS 
A total of 157 individuals were approached to participate in the study.  One hundred and forty 
(89%) agreed to participate. The groups consisted of 98 haemodialysis patients, 21 
peritoneal dialysis patients and 21 pre dialysis patients. There were no significant differences 
between the three groups for age, sex or proportion of patients with diabetes. Mean dialysis 
vintage was longer in the HD group 8.45 years compared to 5.32 years in the PD group 
(table 1, p= 0.001). Diabetic nephropathy was the primary cause of renal failure in both the 
HD group and pre dialysis group, whereas in the PD group diabetic nephropathy and 
hypertension were equally reported. Demographic and clinical profile can be seen in tables 1 
and 2. There was no statistical difference between groups in laxative use (table 1, p=0.39). 






Prevalence of constipation  
Constipation was present in all three groups, however the prevalence of constipation differed 
according to the method used to measure constipation (Table 4). The prevalence of 
constipation using the Rome III criteria was 12.3%; patient perception 46.3% and 25.7% 
using the BSFS. There were also variations in which group had the highest prevalence 
according to the tool used.  PD patients had the highest prevalence of constipation using the 
Rome III criteria; pre dialysis patients had highest prevalence using self-perception and HD 
patients had highest prevalence of constipation using the BSFS. 
 
Diagnostic accuracy of tools to assess constipation  
For the purposes of this analysis, the BSFS was considered the gold standard for diagnosis 
of constipation. This is because the tool is easy to administer, reliable and commonly 
available in our health service for nursing staff to use. In this study, the most sensitive 
methods for detecting those most likely to be constipated were questions 3 and 4 of the 
Rome III criteria; then Rome III total score (see table 5).  The method with the greatest 
specificity was question 2 (asking how often have hard/lumpy stools in last 3 months). The 
kappa value scores for agreement between the BSFS and most variables were all in the poor 
to fair agreement range (0.17-0.33) and only one was statistically significant (question 3 and 
4 combined). When not using the BSFS, then the next best diagnostic test for constipation 
would be completion of the total Rome III score; followed by question 4. These are both good 
to excellent tests as evidenced by the good to excellent AUC scores (AUC values of 0.88 and 






Factors associated with constipation  
A number of factors (table 6) were strongly associated with constipation using the Rome III 
criteria. These included question 3 of the Rome criteria (straining during bowel movement) 
(r= 0.9, p<0.0001).Other factors strongly associated with total Rome III score included 
question 6 (how often in last 3 months had sensation of stool that could not be passed) 
(r=0.87, p<0.0001) and question 4 (how often have hard stools in last 3 months) (r=0.85, 
 p <0.0001)   
 
Multivariate analysis as seen in table 7, indicated that question 4 (how often have hard lumpy 
stools) was the only statistically significant predictor of constipation. Those with a high score for 
question 4 were 2.72 times more likely to be constipated (95% CI 1.02-7.27) 
 
DISCUSSION  
The aim of this study was to describe the bowel habits of people with CKD using three 
different methods. This study found that constipation was common. Regardless of what tool 
was used there were no differences in the prevalence of constipation between either of the 
three groups. This differs from other studies where the prevalence of constipation was found 
to be higher in patients receiving HD using Rome III criteria (Zhang et al 2013:) and in both 
HD and PD patients compared to those not on dialysis using Rome II criteria (Cano et al 
2007). Interestingly in our study, HD patients had highest prevalence of constipation using 
BSFS not Rome criteria, the reason for this is not clear.  
In this study the significant finding was that the prevalence of constipation differed markedly 
depending on the tool used and that prevalence of constipation was highest when assessed 
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by self-perception. This is in line with other literature where self-reporting and perception of 
constipation is high and possibly over reported (Jones et al 2002; Wu et al 2004; Garrigues et 
al 2004; Lee 2011, Dong et al 2014). Clearly relying on perception alone will not give a clear 
indication of whether or not the patient is constipated, and this can make patient assessment 
difficult. 
Despite many patients reporting constipation, the surprising finding was that laxative use in 
all three groups was minimal. Increased laxative use has been reported in both HD and PD 
patients (Cano et al 2007; Sutton et al 2014) therefore the reason for this finding is unclear. 
Laxatives are not routinely prescribed to PD or HD patients in this unit. For PD patients in this 
unit prescribing of laxatives occurs when constipation is suspected due to a dialysis issue.  
 
There are several limitations to our study. These include the cross sectional nature and small 
sample size due to missed recruiting opportunity. However, the strength lies in the fact that 
all three tools were completed simultaneously by participants and complete data obtained on 
all subjects. Those with poor English language skills were not included due to the nature and 
possible sensitivity of the questions. Further research is required on larger sample sizes to 
confirm our findings that variations exist in the prevalence of constipation depending on the 
tool used. 
 
Application to clinical practice  
A bowel management assessment guide was developed as a result of our research findings. 
It is envisaged that this will be used to assist in patient management health care staff. It is 
also is aimed for use by patients to assist in self managing constipation, particularly to 
indicate when laxative use may be beneficial. This assessment guide was developed to 
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incorporate questions from the Rome III criteria and the BSFS (see appendix 3) therefore 
combining the two tools.   
The management guide uses three coloured sections to guide either the patient or nurse as 
to the appropriate action required to maintain good bowel function, in particular prompting the 
need for laxative use.  The green coloured section indicates adequate bowel function, yellow 
and orange sections indicate need for laxatives, especially if no laxative is used. Red 
sections indicates that laxative use is required and recommended. This patient management 
guide aims to be proactive in the management of constipation and is envisaged to be most 
useful for PD patients where constipation can actually affect the dialysis process. Further 
research is required to assess its usefulness and practicality in clinical practice.  
 
Conclusion 
The results of our study indicate that constipation is a common problem, and in our study was 
not predominated by one type of renal replacement modality. Results from our study indicate 
that no single method alone is sufficient for accurately determining if a patient is constipated. 
The common method used by health professionals of relying on the patients’ self-perception 
may give an overestimation of the problem.  Ideally patient assessment of constipation 
should incorporate both the Rome III criteria and BSFS in a method such as the one that has 
been designed as a result of this research. Further research will be required to assess its 

























Mean age in years  
(SD) 
66.6 (13.6) 69.1 (15.6) 64.2 (13.5) 66.6 (13.9) 0.52 
Years on dialysis ( SD) 8.45 (7.7) 5.32 (2.6)  N/A 6.71 (6.45) 0.001 
Gender, n males (%)  59 (60.2) 13 (61.9) 10 (47.6) 82 (58.6) 0.54 
Diabetes, n (%) 38 (38.8) 9 (42.9) 8 (38.1) 55 (39.3) 0.94 
Laxative use ^, n (%) 30 (30.6) 9 (42.9) 5 (23.8) 44 (31.4) 0.39 
No laxatives, n (%) 65 (66.3) 12 (57.1) 16  (76.1) 107 (76.4) 0.39 
Docusate 2 (2.0) 2 (9.5) 1 (4.8) 5(3.6)  
Docusate and senna 12 (12.2) 3 (14.3) 0 (0) 15 (10.7)  
PEG 5 (5.1) 1 (4.8) 2 (9.5) 8 (5.7)  
Other  7 (7.1) 2 (9.5) 2 (9.5) 11 (7.9)  
  
HD: Haemodialysis; PD: Peritoneal Dialysis; PRE: pre dialysis   
 
 












































Diabetic Nephropathy  28 4 6 38 
Glomerular Nephritis 14 2 1 17 
Hypertension 3 4 3 10 
Polycystic Kidney Disease  3 0 5 8 
Reflux Nephropathy  6 2 0 8 
Analgesic Nephropathy 3 2 0 5 
Renal Cell Carcinoma  5 0 0 5 
Other 25 3 6 34 
Uncertain 11 4 0 15 
 























Laxative use#, n (%) 30 (30.6) 9 (42.9) 5 (23.8) 44 (31.4) 









ne glycol  
(5%) 
Polyethyle










Next most common 







# represents participants who consumed at least one laxative 
 
 
HD: Haemodialysis; PD: Peritoneal Dialysis; PRE: Predialysis 
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Functional constipation using 
Rome III total score, n (%) 
13 (13.5) 3 (14.3) 1 (4.8) 17 (12.3) 0.52 
Using BSF, n (%) 
 
28 (28.6) 4 (19.0) 4 (19.0) 36 (25.7) 0.50 
Using self-perception, n (%) 
 
41 (43.6) 9 (42.9) 13 (61.9) 63 (46.3) 0.30 
P value  <0.0001 0.02 0.005 <0.0001 - 
 




















AUC (95% CI) 
Q1 asking / patient 
perception  
72.7 63.0 0.28 0.07 0.68 (0.56-0.78) 
Q2 how regular open 
bowels 
16.7 96.1 0.17 0.08 0.56 (0.45-0.68) 
Q2 and Q4 combined 
 
91.7 43.3 0.23 0.05 0.68 (0.58-0.77) 
Q3 do you strain  
 
91.7 46.2 0.26 0.06 0.69 (0.60-0.78) 
Q4 are the stools hard or 
lumpy score 
91.7 45.6 0.25 0.06 0.81 (0.73-0.90) 
Q3 and Q4 
 
94.4 32.7 0.17 0.04 0.64 (0.54-0.73) 
Q5 incomplete 
evacuation score 
80.6 50.0 0.22 0.06 0.69 (0.6-0.79) 
Q6 sensation can’t pass 
stool score 
74.3 67.0 0.33 0.08 0.70 (0.6-0.8) 
Q7 manual evacuation 
 
40.0 84.6 0.26 0.09 0.63 (0.52-0.75) 
Q9 do you take a 
laxative  
78.8 55.6 0.33 0.09 0.67 (0.56-0.78) 
Rome III total score > 10 
 





Table 6. Factors Associated with Constipation  







Q3 score how often do you open your bowels in last 3 months  
 
0.90 <0.0001 
Q 4 score how often have hard stools in last 3 months 
 
0.85 <0.0001 
Q5 score how often had feeling of incomplete evacuation in last 3 
months 
0.79 <0.0001 
Q6 score how often in last 3 months had sensation of stool that 
could not be passed 
0.87 <0.0001 



































Table 7. Multivariate predictors of constipation  
 B P value Odds Ratio 95% CI 
Q 2 less than 3 times week 2.03 0.11 7.62 0.64-91.31 
Q 3 score >2 1.42 0.28 4.14 0.31-55.54 
Q4 score 1.00 0.04 2.72 1.02-7.27 
Taking any laxative  1.17 0.07 3.22 0.90-11.49 








































Appendix 1.Participant survey 
 
1. In the last 3 months have you suffered from constipation?  
0                                                                                 5                                                                                10 
never always 
                                            rarely                                  sometimes                             often 
2.In the last 3 months how often do you 
generally have a bowel movement  
 Daily 
every 2nd day 
fewer than 3 bowel movements /week 
3. In the last 3 months how often do you 
strain during bowel movements? 
Never/ rarely             
Sometimes                 
Often                           
Most of the time       
Always                         
4. In the last 3 months how often do you have 
hard or lumpy stools? 
Never/ rarely             
Sometimes                 
Often                           
Most of the time      
Always                         
5. In the last 3 months how often do you have 
a feeling of incomplete emptying after bowel 
movement? 
 
Never/ rarely             
Sometimes                 
Often                           
Most of the time       
Always                        
6. In the last 3 months how often did you 
have a sensation that the stool could not be 
passed when having a bowel movement? 
Never/ rarely             
Sometimes                 
Often                           
Most of the time      
Always                         
7. In the last 3 months how often did you 
press on or around your bottom or remove 
stool in order to complete a bowel 
movement? 
Never/ rarely             
Sometimes                 
Often                           
Most of the time       
Always                         
8. In the past 3 months using the Bristol Stool 
Form Scale identify your usual stool  form 
type  
1      2        3        4       5        6        7 
9. Do you take laxatives  YES                            NO 
10.If you are taking laxatives please list what 
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